Pan-Neurofascin Antibody-Associated Nodopathy: A Critical Guillain-Barré Syndrome Mimic in the Differential Diagnosis-Report of Two Cases. (PubMed, Case Rep Crit Care) - Sep 21, 2026 - "A transient or mild clinical response-or an initial lack of response-to standard GBS-treatment followed by rapid and severe deterioration in cases initially presenting as GBS should be considered a red flag warranting evaluation for AN-associated antibodies. Recognition of this important GBS mimic is critical, as it requires an alternative treatment approach with rituximab, which has been associated excellent clinical outcomes."
Journal • Critical care • Immunology • Pain • Respiratory Diseases
|
|
Alicia Alonso-Jiménez; Andrea Nemethova; Ingrid Baar; Willem De Ridder
|